Welby

Welby EBIT Margin

The EBIT Margin (Operating Margin) of Welby (4438.T) as of Oct 19, 2026 is -71.23 %. In the previous year, EBIT Margin (Operating Margin) was -154.30 % — a change of -53.84% (higher).

EBIT Margin

-71.23 %

YoY

-53.84%

Last updated:

EBIT Margin (Operating Margin) of Welby is 2025 -71.23 % . EBIT Margin (Operating Margin) of Welby was 2024 -154.30 % . It decreases by -53.84% higher compared to the previous year.

For Welby, the operating (EBIT) margin of -71.5% is down versus -11.3% a few years ago.

The Welby EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
19.32 JPY
Jan 1, 2019
-0.57 JPY
Jan 1, 2020
-38.36 JPY
Jan 1, 2021
-11.26 JPY
Jan 1, 2022
5.80 JPY
Jan 1, 2023
-87.45 JPY
Jan 1, 2024
-154.30 JPY
Jan 1, 2025
-71.23 JPY
The Welby EBIT Margin history
YEAREBIT MarginYoY
-71.23 %-53.84%
-154.30 %+76.44%
-87.45 %-1,609.02%
5.80 %-151.46%
-11.26 %-70.64%
-38.36 %+6,675.83%
-0.57 %-102.93%
19.32 %-221.47%
-15.90 %-70.40%
-53.73 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby Inc is a Japanese company operating in the Health Care sector, headquartered in Chuo-Ku, Tokyo. The company has 40 employees and went public on March 29, 2019, with the ticker 4438.T and ISIN JP3155410008. Welby Inc develops patient health record platform services, focusing on creating a personal health record (PHR) platform within the medical field. The company provides two main services: a disease solution service, which involves developing PHR platforms for pharmaceutical companies upon request, and Welby My Carte, a cloud-based service designed to support patients in managing their daily health habits, particularly for conditions such as diabetes and hypertension. The company's website is https://welby.jp/. Welby Inc operates with a focus on digital health solutions, aiming to enhance patient self-management and provide tailored health record systems for medical and pharmaceutical partners. The company's business model centers on delivering technology-driven health management tools that support both healthcare providers and patients. As a publicly traded company, Welby Inc is listed on the Tokyo Stock Exchange. The company's operations are based in Chuo-Ku, Tokyo, and it serves a market that includes healthcare institutions and pharmaceutical firms seeking digital health solutions. The firm's services are designed to improve patient engagement and health outcomes through accessible, technology-based platforms. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

EBIT Margin (Operating Margin) of Welby is -71.23 % in 2025.

EBIT Margin (Operating Margin) of Welby changed from -154.30 % to -71.23 %, representing a -53.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Welby since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Welby with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Welby

All Key Metrics — Welby